|
Atomistry » Zinc » PDB 6nkn-6o3p » 6nzt | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Atomistry » Zinc » PDB 6nkn-6o3p » 6nzt » |
Zinc in PDB 6nzt: Crystal Structure of Hcv NS3/4A Protease in Complex with VoxilaprevirProtein crystallography data
The structure of Crystal Structure of Hcv NS3/4A Protease in Complex with Voxilaprevir, PDB code: 6nzt
was solved by
T.C.Appleby,
J.G.Taylor,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Other elements in 6nzt:
The structure of Crystal Structure of Hcv NS3/4A Protease in Complex with Voxilaprevir also contains other interesting chemical elements:
Zinc Binding Sites:
The binding sites of Zinc atom in the Crystal Structure of Hcv NS3/4A Protease in Complex with Voxilaprevir
(pdb code 6nzt). This binding sites where shown within
5.0 Angstroms radius around Zinc atom.
In total only one binding site of Zinc was determined in the Crystal Structure of Hcv NS3/4A Protease in Complex with Voxilaprevir, PDB code: 6nzt: Zinc binding site 1 out of 1 in 6nztGo back to Zinc Binding Sites List in 6nzt
Zinc binding site 1 out
of 1 in the Crystal Structure of Hcv NS3/4A Protease in Complex with Voxilaprevir
Mono view Stereo pair view
Reference:
J.G.Taylor,
S.Zipfel,
K.Ramey,
R.Vivian,
A.Schrier,
K.K.Karki,
A.Katana,
D.Kato,
T.Kobayashi,
R.Martinez,
M.Sangi,
D.Siegel,
C.V.Tran,
Z.Y.Yang,
J.Zablocki,
C.Y.Yang,
Y.Wang,
K.Wang,
K.Chan,
O.Barauskas,
G.Cheng,
D.Jin,
B.E.Schultz,
T.Appleby,
A.G.Villasenor,
J.O.Link.
Discovery of the Pan-Genotypic Hepatitis C Virus NS3/4A Protease Inhibitor Voxilaprevir (Gs-9857): A Component of Vosevi®. Bioorg.Med.Chem.Lett. V. 29 2428 2019.
Page generated: Tue Oct 29 04:03:00 2024
ISSN: ESSN 1464-3405 PubMed: 31133531 DOI: 10.1016/J.BMCL.2019.03.037 |
Last articlesZn in 9JYWZn in 9IR4 Zn in 9IR3 Zn in 9GMX Zn in 9GMW Zn in 9JEJ Zn in 9ERF Zn in 9ERE Zn in 9EGV Zn in 9EGW |
© Copyright 2008-2020 by atomistry.com | ||
Home | Site Map | Copyright | Contact us | Privacy |